胰十二指肠联合血管切除和重建治疗胰头部恶性肿瘤

目的探讨联合血管重建胰十二指肠切除术的适应证和方法。方法回顾 1994年4月～ 2 0 0 1年 3月多家协作医院 4 4例联合血管重建胰十二指肠切除术的资料。本组 4 4例行胰十二指肠切除 ,全组均联合肠系膜上静脉 门静脉切除 ,其中合并肠系膜上动脉和肝动脉切除重建者分别为 4例和 2例。 1例胰头癌因与下腔静脉前壁粘紧不能分开则合并下腔静脉前壁部分切除修复。结果本组围手术期死亡 3例 (7% )。无胆、胰瘘及人工血管感染发生。病理检查结果 :胰腺神经内分泌恶性肿瘤 1例 ,其余均为腺癌。切除血管内膜和胰腺边缘均无肿瘤侵润。本组失访 2例。随访时间 3～ 87个月 ,7例死于术后 7个月至 3年 ,其中 6例为合并肠系膜上动脉和肝动脉切除重建者。存活超过 3年者 2 1例 ,超过 5年者 6例 ,其余病例尚在随访中。结论在选择适宜的病例中施行联合切除血管的胰头癌根治术可提高其切除率 ,延长存活时间 ,手术安全。     

����Ѫ���ؽ�����ʮ��ָ���г�����42�����棩

目的 探讨联合血管重建胰十二指肠切除术的适应证和方法。方法 回顾自1994年4月至2001年3月多家协作医院42例联合血管重建胰十二指肠切除术的经验。42例行胰十二指肠切除，其中1例胰头癌累及结肠肝曲合并右半结肠切除。全组均联合肠系膜上静脉门静脉（SMVPV）切除，其中合并肠系膜上动脉（SMA）和肝动脉（HA）切除重建者分别为4例和2例。1例胰头癌因与下腔静脉前壁粘连紧密不能分开则合并下腔静脉前壁部分切除修复。结果 围手术期死亡3例（7.1%）。无胆胰瘘及人工血管感染并发症，病理检查结果：胰腺神经内分泌恶性肿瘤1例，其余均为腺癌，切除血管内膜和胰腺切缘均无肿瘤浸润。失访2例。随访时间3－87个月，7例死于术后7个月至3年，其中6例为合并SMA、HA切除重建者，存活超过3年19例，超过5年6例。其余病例尚在随访中。结论 在选择适宜的病例中施行联合切除血管的胰头癌根治术可提高其切除订，延长病人存活时间。     

保留胰头十二指肠的胰腺钩突癌切除联合静脉切除重建一例

目的 探讨在胰腺钩突癌根治术中行保留胰头十二指肠的胰腺钩突癌切除的手术技巧和应用价值。方法 回顾性分析泰州市人民医院对1例胰腺钩突癌患者实施保留胰头十二指肠的胰腺钩突癌切除联合静脉切除重建的临床资料。术前CT提示钩突延伸至SMA左侧,而肿瘤位于延伸的钩突下部,距离胰头十二指肠、胆胰管汇合部、主胰管均较远,幽门上下、肝十二指肠韧带未见肿大淋巴结,肿瘤侵犯区域位于肠系膜上静脉（SMV）、肠系膜上动脉（SMA）以及十二指肠升部。结果 施行保留胰头十二指肠的胰腺钩突癌切除联合血管切除重建,同时将受累及的十二指肠、近段空肠切除、十二指肠水平部-空肠侧侧吻合。首先采用动脉优先入路技术探查SMA,发现肿块仅侵犯动脉鞘及空肠分支,采用动脉鞘切除、受侵犯的分支切断结扎,保留了SMA起始部主干。再探查SMV,见主干受侵约3 cm,采用SMV节段性切除重建。距离肿块约1 cm离断胰腺,离断缺血的空肠肠系膜及空肠肠管、离断十二指肠水平部,行十二指肠水平部-小肠侧侧吻合。结论 基于胰腺钩突癌部位及侵犯情况,在保证根治的前提下,采用保留胰头十二指肠的胰腺钩突癌切除（或联合血管切除重建）,可避免手术创伤更大的胰十二指肠切除,保证了消化道的正常结构和生理功能,最大限度地保留患者胰腺内外分泌功能,改善术后营养状况,有利于术后早期辅助放化疗。     

扩大胰十二指肠切除术治疗胰头癌

目的 探讨扩大的胰十二指肠切除术的适应证和手术要点.方法 回顾分析12例因胰头癌行胰十二指肠切除合并肠系膜上静脉-门静脉切除术的临床资料.结果 本组患者无围手术期死亡,无胆瘘、上消化道大出血及人工血管感染等并发症发生.术后出现胃肌轻瘫3例,胰瘘1例,均经保守治疗后好转,术后复查彩超、人工血管及门静脉内均无血栓形成.术后病理报告:浸润性导管癌8例,胰腺细胞癌3例,恶性淋巴管瘤1例,切除血管上下缘,无肿瘤浸润.胰腺切缘没有肿瘤累及,门静脉受癌肿侵犯8例,炎性粘连4例.术后9个月死于重度营养不良1例,术后18个月死于癌肿复发肝转移1例,其余10例目前尚在随访中,其中存活3年3例,2年4例,1年3例.结论 扩大的胰十二指肠切除术能提高胰头癌手术切除率,改善患者的生活质量和提高生存率,应该作为胰头癌患者合理手术方式的一种选择.     

规范化区域淋巴结清扫在胰头癌胰十二指肠切除术中的临床意义

目的 探讨规范化区域淋巴结清扫在胰头癌胰十二指肠切除术(PD)中的临床意义.方法 对2008 年1 月至2010 年10 月收治的48 例胰头癌患者施行在常规whipple 基础上进行规范化区域淋巴结清扫.采用JPS 的淋巴结分组标准,规范化区域淋巴结清扫的重点清扫肝总、肝固有动脉周围所有淋巴结(8a,8p)、腹腔干周围淋巴结(9)、肝十二指肠韧带区所有淋巴结(12abp)、胰十二指肠后的淋巴结(13a、13b)、从SMA 开口至胰十二指肠下动脉(IPDA)间的SMA 右侧的淋巴结(14abcd)及胰十二指肠前的淋巴结(17a、17b)、腹腔干至肠系膜下动脉(IMA)间的腹主动脉与下腔静脉前面的淋巴结(16a2、16b1)并包含Gerota 筋膜.结果 48 例胰腺癌患者施行规范化区域淋巴结清扫,术中常规行胰腺、胆管断面检查,证实无癌残留.2 例患者肠系膜上静脉部分切除并血管重建,术后多脏器功能衰竭死亡1 例.并发少量胰瘘2 例,发生胃瘫1 例,切口感染3 例,急性左心衰1 例,均治愈.48 例患者累计清扫淋巴结716 个,平均每例14.9 个.其中有20 例(41.6%)发生淋巴结转移,其中以胰十二指肠后(13a、13b)(14/48)29.1%、肠系膜上动脉周围淋巴结缔组织(14abcd) (8/48)16.7%发生率最高;N1 阳性(8/20,40.0%),N2 阳性(6/20,30.0%),N3 阳性(6/20,30.0%).结论 规范化区域淋巴结清扫可以有效清扫区域内更多淋巴结和后腹膜组织,同时没有增加其手术的死亡率和并发症.     

胰头癌的外科诊断与治疗

目的: 探讨胰头癌的早期诊断和外科治疗方法.方法: 对1981年至2001年间我院收治的205例胰头癌病人进行回顾分析.结果: 全组行根治性切除48例,切除率为23.4%;发生并发症15例(31.3%),死亡4例(8.3%).1981年至1991年间胰头癌手术切除率和并发症的发生率分别为14.5%和55.6%,而1992年至2001年间胰头癌手术切除率为27.3%,并发症发生率为25.6%;比较两阶段的手术切除率,有显著性差异(P<0.05).结论: 要提高胰头癌的治愈率关键仍在胰头癌的早期诊断及围手术期的恰当处理.     

保留十二指肠的胰头切除术治疗胰腺囊腺癌

目的: 探讨胰腺囊腺癌的临床特点和治疗策略.方法: 回顾分析8例胰腺囊腺癌病人的诊断过程和治疗方法.结果: 8例病人中肿瘤位于胰头颈部5例,体尾部3例;保留十二指肠的胰头切除术4例,胰头十二指肠切除术1例,胰体尾联合脾切除术1例,有2例行囊肿内引流及外引流术,平均随访12.4个月,未切除肿瘤病人生存时间分别为6个月和10个月.结论: 胰腺囊腺癌的诊断困难,了解其临床及术中特点有助于减少误诊,治疗方法以局部切除为好.     

扩大胰十二指肠切除术中联合肝动脉、肝固有动脉与髂内静脉切除重建应用的可行性研究

目的探讨在行扩大胰十二指肠切除联合血管切除术中应用肝动脉(HA)或肝固有动脉(PHA)与肠系膜上动脉(SMA)吻合、髂内静脉(IIV)与肠系膜上静脉(SMV)或门静脉(PV)吻合应用的可行性。方法解剖20具成人尸体的HA、PHA、SMA、SMV、PV、左IIV及右IIV,测量各血管长度、血管壁厚度和血管直径;用多层螺旋CT扫描、磁共振血管成像、彩色多普勒、选择性动脉造影检测20例胰头癌患者和本组5例患者的上述血管,并进行比对。根据比对结果,对5例已经发生血管浸润的胰头癌行扩大胰十二指肠切除术,行HA或PHA与SMA、IIV与SMV或PV吻合重建。结果尸体的HA-PHA长度为(5.50±1.50)cm,血管壁厚度为(0.20±0.01)mm,血管直径为(5.02±1.32)mm;SMA长度为(4.00±1.00)cm,血管壁厚度为(0.21±0.01)mm,血管直径为(6.05±1.06)mm。左IIV、右IIV及PV主干或SMV血管直径分别为(11.06±0.16)mm、(11.10±0.13)mm及(11.56±0.20)mm;左IIV、右IIV及PV主干或SMV的管壁厚度分别为(0.10±0.01)mm、(0.10±0.02)mm和(0.10±0.02)mm。活体多层螺旋CT扫描、磁共振血管成像、彩色多普勒、选择性动脉造影显示HA或PHA和SMA管壁厚度及血管直径分别稍比尸体解剖大0.1 mm和0.3 mm,差异均无统计学意义(P>0.05),而HA-PHA的长度比SMA长1～2 cm(P<0.05)。5例行扩大胰十二指肠切除术同时联合HA或PHA和SMA、IIV和PV或SMV切除重建患者的生存期均长于同期姑息性或放弃手术者,无一例发生远期并发症。结论有血管侵犯的胰头癌不是根治术的绝对禁忌证;就本组5例扩大胰十二指肠切除联合血管切除重建的患者比同期发生血管浸润的胰头癌仅施行探查或姑息性手术的33例患者生存时间而言,前者生存时间明显延长;HA或PHA和IIV是最好的自体血管代用材料,没有明显增加术后并发症;熟识尸体局部解剖结构对手术医生有一定的指导性意义。     

胰腺十二指肠联合损伤的诊断和治疗

目的 探讨胰腺十二指肠联合损伤的诊断和治疗方法,以提高临床疗效.方法 回顾性分析11例胰腺十二指肠联合损伤的临床资料.胰头十二指肠联合损伤7例,胰体十二指肠联合损伤4例;全组施行胰十二指肠切除术2例,胰头、十二指肠修补术5例(包括胰头修补+十二指肠修补术1例,胰头修补+带蒂空肠瓣十二指肠修复术2例,胰头、十二指肠修补+十二指肠憩室化手术2例);胰体尾部修补+十二指肠修补术1例,带脾脏胰体尾部切除+十二指肠修补术1例,胰体尾切除+十二指肠切除+空肠十二指肠端端吻合术2例.结果 术后3例发生胰漏(27.3%),经持续低负吸引治愈.全组9例痊愈(81.8%),2例死亡(18.2%).结论 早期诊断、及时手术以及正确的手术方式是治疗成功的关键.     

联合血管重建的胰十二指肠切除术治疗胰头癌的经验总结

由于胰腺的解剖位置特殊,造成胰腺癌手术切除率低、术后易复发及生存时间短等特点.Fortner[1-2]提出了分别联合门静脉、肠系膜上静脉、肠系膜上动脉、肝动脉和腹腔干等联合血管重建的胰十二指肠切除术(PD),提高了胰腺癌切除率.从20世纪90年代以来,有关联合血管重建的胰十二指肠切除术的研究逐渐增多,使胰头癌的切除率从10%～20%提高至26%～46%[3-4],手术病死率＜5%,5年生存率从原来的8%提高到20%[5-6].     

小肠自体移植式扩大胰腺癌根治术的疗效与安全性分析：附2例报告

背景与目的 局部进展期胰腺癌（LAPC）的治疗方法在不断更新，且随着血管重建技术与自体器官移植技术的进步，血管侵犯的LAPC的手术根治率也极大提高。本文探讨小肠自体移植式扩大胰腺癌根治术的可行性与安全性。方法 回顾性分析中国人民解放军火箭军特色医学中心2022年5月—2023年5月收治的肠系膜根部受侵的2例LAPC患者的临床资料。2例患者均为女性，分别为66岁和58岁，术前影像学检查提示胰腺钩突恶性肿瘤，肿瘤侵犯并包绕肠系膜上动脉（SMA）及空肠动脉分支。2例患者术前一般情况可，均有十二指肠梗阻表现而未实施化疗，术前心、肺、肝、肾功能经评估患者均能耐受手术，实施小肠自体移植式扩大胰腺癌根治术。手术的关键是将小肠连同肿瘤标本一并切除至体外，再迅速移除标本，后遵循“先动脉、后静脉”的顺序进行SMA/肠系膜上静脉（SMV）重建。结果 2例患者的手术均顺利实施，患者1使用脾动脉翻转与SMA进行重建，SMV与门静脉（PV）对端吻合，小肠热缺血时间为24 min，术后病理诊断为胰腺低分化腺癌。患者2使用SMA端端吻合重建，SMV与PV对端吻合，小肠热缺血时间为18 min，术后病理诊断为胰胆管型壶腹癌。2例患者术后恢复均良好，没有出现动静脉血栓，术后住院时间分别为25 d和21 d。截至2023年8月1日，2例患者分别已在门诊随访12个月与2个月，随访期间患者一般情况良好，除患者2血糖控制尚不平稳外，2例均未见复发或转移证据。结论 从对2例病例回顾性分析结果看，对于侵犯肠系膜根部的LAPC患者采用小肠自体移植式的扩大根治术可以安全成功实现，为此类患者提供了一种可以获得解除病痛、增加生存机会的治疗选择。     

肠系膜上动脉路径在胰十二指肠切除及合并血管切除术中的应用

目的：探讨经肠系膜上动脉途径行胰头十二指肠切除及合并血管切除的可行性及优劣。 方法：2012年9月—2014年2月采用肠系膜上动脉旁路径的方法实施胰头十二指肠切除术治疗胰头癌及壶腹周围癌16例,其中实施门静脉、肠系膜上静脉切除重建手术5例。患者均首先显露、游离肠系膜上动、静脉并清除其周围的神经淋巴组织,再打通胰后隧道并切断胰腺颈部,最后切除胰腺钩突或被侵犯的门静脉、肠系膜上静脉。 结果：15例术后顺利恢复后出院,1例术后出现肾功能衰竭、肺部感染,放弃治疗自动出院。术中平均出血量为470 mL,平均手术时间4.5 h,无手术中及术后死亡。5例术后出现胰瘘等并发症,均经保守治疗后痊愈。切缘病理检查均阴性,淋巴结及后腹膜神经、淋巴组织阳性检出率较高。 结论：经肠系膜上动脉途径行胰头十二指肠切除术治疗胰头癌及壶腹周围癌安全可行,并可增加R0切除率。     

Viszeralarterienrekonstruktionen mit Homografts bei Resektionen des Pankreas

BACKGROUND: At present, surgical treatment with R(0) resection offers the only chance of cure for patients suffering from pancreatic cancer. Carcinomas of the pancreas are frequently diagnosed at an inoperable stage because of local tumor progression by vessel wall infiltration. In a small series of patients, efforts have been made to increase curative resection rates for advanced pancreatic cancer by excision and reconstruction of the involved visceral arteries. Whether this provides clinical benefit remains uncertain. METHODS: Since 2001 we have been employing "en bloc" tumor resection for advanced pancreatic carcinomas with extended infiltration of visceral vessels. Technical experience was gained previously by performing portal vein resection as well as arterial excision and reconstruction by direct anastomosis in the presence of malignant wall infiltration. A total of ten patients underwent vascular reconstruction by arterial homograft interposition. In six of ten cases, combined extended reconstructions of the hepatic and superior mesenteric arteries were performed. One patient died during the perioperative course due to fulminant bleeding. One patient developed severe diarrhea. During a 3- to 18-month follow-up, one case of liver metastasis and one case of local tumor recurrence were documented. CONCLUSIONS: In selective cases, operability and R(0) resection can be achieved in advanced pancreatic cancer by performing extended resection procedures with vascular reconstruction using arterial homografts. Vascular substitution of visceral arteries can be conducted without ischemic disturbances of the small bowel and liver. Only a few perioperative complications were observed.     

胰头癌联合门静脉区域切除的临床价值

目的探讨胰腺癌联合门静脉区域切除的临床价值,及评价区域切除术中肿瘤侵犯门静脉后以颈内静脉替代门静脉的效果。方法回顾性分析2000年1月-2003年1月间天津医科大学附属肿瘤医院6例行胰头癌联合门静脉切除并用颈内静脉替代门静脉修复的患者的临床资料。结果本组6例行胰头癌联合门静脉切除并用颈内静脉替代门静脉修复,术后病理均证实肿瘤侵犯累及门静脉和／或肠系膜上静脉,术后生存时间17～49个月,平均23．2个月,其中2例存活超过3年,最长的1例术后无瘤生存达4年1个月。结论对于胰头癌局部浸润肠系膜上静脉和／或门静脉,但无远处转移的患者,应积极行手术切除。胰腺癌联合门静脉切除后,行颈内静脉替代门静脉修复是一种有效的方法,可以提高手术切除率,减少术后并发症,延长患者生存期。     

En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients

BACKGROUND: To assess in-hospital complication rates and survival duration after en bloc vascular resection (VR) for infiltration of pancreatic malignancies in major vessels. METHODS: Between 1994 and 2005, 585 patients underwent potentially curative pancreatic resection without adjuvant chemotherapy. Four hundred forty-nine patients (77%) underwent standard oncologic resection (VR-), whereas 136 (23%) received VR (VR+). For calculation of in-hospital morbidity and mortality rates, all 136 patients who underwent VR were considered. In contrast, for survival analysis, only pancreatic adenocarcinoma patients (n = 100) were included. RESULTS: One hundred twenty-eight VR+ patients underwent portal or superior mesenteric vein resection and 13 hepatic artery (HA) or superior mesenteric artery (SMA) resection. In 5 patients, synchronous VR addressing both the mesenterico-portal axis and either the HA or SMA was performed. In-hospital morbidity and mortality rates of VR- patients (39.7%/4.0%) nearly equaled that of VR+ patients (40.3%/3.7%). From the 100 patients with pancreatic adenocarcinoma, histopathology confirmed "true" vascular invasion in 77 patients. Twenty-three patients had peritumoral inflammation, mimicking tumor invasion. Median survival was 15 months (11.2-18.8) in patients with histopathologic proven vascular invasion and 16 months (14.0-17.9) in those without (P = 0.86). Two-year survival probabilities were 36% (without) versus 34% (with vascular invasion; P = 0.9). Among VR+ patients with histopathologically evidenced vascular invasion, 19 survived longer than 30 months, and 6 were still alive 5 years after surgery. Multivariate modeling identified nodal involvement (N1) and poor grading (G3) as the only predictors of decreased survival. Evidence of vascular invasion had no adverse impact on survival. CONCLUSION: Postoperative morbidity and mortality rates after en bloc VR are comparable with "standard" pancreatectomy procedures. Median survival of 15 months in patients with vascular invasion is superior to that of patients who undergo palliative therapy and nearly equals that of patients who are not in need for VR.     

侵犯重要血管的胰头癌切除的可行性探讨

目的：总结5年来所见侵犯重要血管的胰头癌诊治经验。方法：对2002～2006年间收治的61例侵犯重要血管的胰头癌的临床资料进行回顾性分析。结果：本组61例中,侵犯门静脉11例,侵犯肠系膜上血管13例,联合侵犯门静脉、肠系膜上血管12例,侵犯其他血管但无广泛转移者共13例,广泛转移者12例。61例病人中行B超检查的58例,CT检查42例,行MRCP18例,ERCP15例。20例行单纯胰十二指肠切除术,4例联合血管切除的胰十二指肠切除术,2例行联合血管切除的全胰切除术,其余行Roux-en-Y胆肠内引流术。全组无手术死亡。结论：对侵犯重要血管的胰头癌,B超可用于筛查,而CT结合MRCP/ERCP对于确定肿瘤的病变范围、血管浸润等有较高价值。对于满足适应证的病例,应积极采用联合血管切除的胰十二指肠切除术;对于不适合者,可行胆肠内引流,以改善病人生活质量和延长生存时间。     

Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience

BACKGROUND: Liver tumors with inferior vena cava (IVC) involvement may require combined resection of the liver and IVC. This approach, with its high surgical risks and poor long-term prognosis, was precluded until the development of neoadjuvant chemotherapy, portal vein embolization, reinforced vascular prostheses, and technical advances in liver transplantation. METHODS: We reviewed 22 cases of hepatectomy with retrohepatic IVC resection and reconstruction. The patients had a median age of 51.5 years (range, 32.8-75.3 years). Indications for resection were: liver metastases (n = 9), cholangiocarcinoma (n = 8), hepatocellular carcinoma (n = 2), other cancers (n = 3). The liver resections carried out included 18 first, 3 second, and one third hepatectomy. Segment 1 (caudate lobe) was included in the specimen in 19 cases (86%). Resection concerned 1 to 6 liver segments (median = 5.0). Vascular control was achieved by vascular exclusion of the liver preserving the caval flow (n = 1), standard vascular exclusion of the liver (n = 12), in situ cold perfusion of the liver (n = 9). Ex situ surgery was not necessary in any case. Venovenous bypass was used in 12 cases. The IVC was reconstructed with a ringed Gore-Tex tube graft (n = 10), primarily (n = 8), or by caval plasty (n = 4). A main hepatic vein was reimplanted in 6 cases: into the native IVC (n = 4) or into a Gore-Tex tube graft (n = 2). RESULTS: One patient died (4.5%) due to catheter infection, 7 days after in situ cold perfusion with replacement of the vena cava. Eight patients (36%) had no complications and 14 patients (64%) had 23 complications. In all but 1 case, the complications were transient and successfully controlled. The patients stayed in intensive care for 3.3 +/- 2.0 days and in the hospital for 17.7 +/- 7.8 days. All vascular reconstructions were patent at last follow-up. With median follow-up of 19 months, 10 patients died of tumor recurrence and eleven were alive with (n = 5) or without (n = 6) disease. Actuarial 1-, 3-, and 5-year survival rates were 81.8%, 38.3%, and 38.3%, respectively. CONCLUSIONS: IVC resection and reconstruction combined with liver resection can be safely performed in selected patients. The lack of alternative treatments and the spontaneous poor prognosis justify this approach, provided that surgery is carried out at a center specialized in both liver surgery and liver transplantation. The development of adjuvant chemotherapy regimens is required to improve the long-term results of this salvage surgery.     

Extraanatomic lateral reconstruction to the popliteal vessels.

OBJECTIVES: To describe the lateral approach to the popliteal artery in reconstructions after soft tissue sarcoma resection in the thigh. DESIGN: Case reports. Subjects Four patients with soft tissue sarcoma. METHODS: Extraanatomic reconstruction of the resected artery and vein in the medial part of the thigh was performed. Vessel reconstruction was performed before tumor resection to avoid leg ischemia. RESULTS: In all four patients the artery was replaced by using the contralateral saphenous vein, while the femoral vein was replaced in two cases using e-PTFE. Post-operative complications included one large lymphatic collection and a deep wound infection. Arterial primary graft patency was 100% after 1-7 years. Patency of the e-PTFE-venous graft was 0% without further consequences. CONCLUSIONS: The extraanatomic lateral replacement of the vessels in the thigh is an elegant method in difficult vascular reconstructions after soft tissue sarcoma resection or debridement for deep vascular infections.     

Left Renal Vein Graft for Vascular Reconstruction in Abdominal Malignancy

Background Advanced abdominal malignancies are occasionally invasive for the major blood vessels, such as the portal vein (PV), inferior vena cava (IVC), and major hepatic veins (HVs), and complete removal of the tumors is required for patients undergoing vascular resection and reconstruction. We used left renal vein (LRV) grafts for vascular reconstruction in patients with these malignancies and evaluated their clinical relevance. Methods A total of 113 patients underwent vascular resection including the PV (42 patients), IVC (68 patients), and HV (3 patients) for hepatobiliary-pancreatic or abdominal tumor resection. Of these, 11 patients underwent vascular reconstruction with a LRV graft of the PV, superior mesenteric vein (SMV), and HVs in 3 patients each, and the IVC in 2 patients. The HVs were resected with segmentectomy involving Couinaud’s segments VII, VIII, and IV; VII, VIII, and II; or III, IV, VIII in each patient. The PV and SMV were resected in 5 patients undergoing pancreaticoduodenectomy for pancreatic carcinoma, and in 1 patient being treated with extended right hepatectomy and pancreaticoduodenectomy for hepatic hilar carcinoma. The IVC was partially resected in 1 patient with advanced colon cancer and 1 with malignant schwannoma. Results The mean graft length of LRV obtained was 3.6 (3.5–4.0) cm. The graft was used as a tube in 9 patients, and as a patch in 2 patients. The mean duration of clamping time was 41.9 (35–60) min. Portal vein thrombosis was encountered in 2 patients, and anastomotic stenosis in 1 patient. Other morbidity was not related to vascular reconstruction. One patient who underwent extended right hepatectomy and pancreaticoduodenectomy died of liver failure in the hospital. The serum creatinine level after surgery did not deteriorate except in the one patient who died in the hospital. Graft patency was maintained during the follow-up period in all patients. Conclusions A LRV graft may enhance the possibility of vascular reconstruction without deteriorating serum creatinine level, and it provides sound graft patency.